Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A

Virchows Archiv

Volumn 449, Issue 4, 2006, Pages 402-409

  Lai, Maode ^a   Lü, Bingjian ^a   Xing, Xiaoming ^a   Xu, Enping ^a   Ren, Guoping ^a   Huang, Qiong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chromogranin A; Gastrointestinal tract; Neuroendocrine tumor; Secretagogin; Small cell lung cancer

Indexed keywords

CALCIUM BINDING PROTEIN; CHROMOGRANIN A; NEURON SPECIFIC ENOLASE; SECRETAGOGIN; SYNAPTOPHYSIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ARTICLE; CARCINOID; CARCINOMA; CLINICAL PRACTICE; COLORECTAL CANCER; CONTROLLED STUDY; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; OVARY TUMOR; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RECTUM TUMOR; STOMACH CANCER; TUMOR DIFFERENTIATION;

CALCIUM-BINDING PROTEINS; CHROMOGRANIN A; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEUROENDOCRINE TUMORS; NEUROSECRETORY SYSTEMS; PATHOLOGY, SURGICAL; PHOSPHOPYRUVATE HYDRATASE; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 33748992337     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0263-9     Document Type: Article

References (31)

1. Barakat MT, Meeran K, Bloom SR (2004) Neuroendocrine tumours. Endocr Relat Cancer 11:1-18
2. Birkenkamp-Demtroder K, Wagner L, Brandt Sorensen F, Bording Astrup L, Gartner W, Scherubl H, Heine B, Christiansen P, Orntoft TF (2005) Secretagogin is a novel marker for neuroendocrine differentiation. Neuroendocrinology 82:121-138
3. Campbell LK, Thomas JR, Lamps LW, Smoller BR, Folpe AL (2003) Protein gene product 9.5 (PGP9.5) is not a specific marker of neural and nerve sheath tumours: an immunohistochemical study of 95 mesenchymal neoplasms. Mod Pathol 16:963-969
4. Cras-Meneur C, Inoue H, Zhou Y, Ohsugi M, Bernal-Mizrachi E, Pape D, Clifton SW, Permutt MA (2004) An expression profile of human pancreatic islet mRNAs by serial analysis of gene expression (SAGE). Diabetologia 47:284-299
5. Gartner W, Lang W, Leutmetzer F, Domanovits H, Waldhausl W, Wagner L (2001) Cerebral expression and serum detectability of secretagogin, a recently cloned EF-hand Ca2+-binding protein. Cereb Cortex 11:1161-1169
6. Gosney JR, Gosney MA, Lye M, Butt SA (1995) Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma. Thorax 50:116-120
7. Guinee DG Jr, Fishback NF, Koss MN, Abbondanzo SL, Travis WD (1994) The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies. Am J Clin Pathol 102:406-414
8. Howe MC, Chapman A, Kerr K, Dougal M, Anderson H, Hasleton PS (2005) Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 46:195-201
9. Kimura N, Pilichowska M, Okamoto H, Kimura I, Aunis D (2000) Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumours and pancreatic endocrine tumours. Mod Pathol 13:140-146
10. Lantuejoul S, Moro D, Michalides RJ, Brambilla C, Brambilla E (1998) Neural cell adhesion molecules (NCAM) and expression in neuroendocrine lung tumours. Am J Surg Pathol 22:1267-1276
11. Loy TS, Darkow GV, Quesenberry JT (1995) Immunostaining of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations. Am J Surg Pathol 19:173-182
12. Mani S (1994) Carcinoids of the rectum. J Am Coll Surg 179:231-248
13. Molenaar WM, Baker DL, Pleasure D, Lee VM, Trojanowski JQ (1990) The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. Am J Pathol 136:375-382
14. Pagani A, Fischer-Colbrie R, Sanfilippo B, Winkler H, Cerrato M, Bussolati G (1992) Secretogranin II expression in Ewing's sarcomas and primitive neuroectodermal tumours. Diagn Mol Pathol 1:165-172
15. Park HC, Seong J, An JH, Kim J, Kim UJ, Lee BW (2005) Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion. Int J Radiat Oncol Biol Phys 61:1523-1534
16. Patriarca C, Pruneri G, Alfano RM, Carboni N, Ermellino L, Guddo F, Buffa R, Siccardi AG, Coggi G (1997) Polysialylated N-CAM, chromogranin A and B, and secretogranin II in neuroendocrine tumours of the lung. Virchows Arch 430:455-460
17. Pisick E, Skarin AT, Salgia R (2003) Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumours. Anticancer Res 23:3379-3396
18. Rindi G, Kloppel G (2004) Endocrine tumours of the gut and pancreas tumour biology and classification. Neuroendocrinology 80:12-15
19. Sawady J, Mendelsohn G, Sirota RL, Taxy JB (1989) The intrathyroidal hyperfunctioning parathyroid gland. Mod Pathol 2:652-657
20. Schmid KW, Kroll M, Hittmair A, Maier H, Totsch M, Gasser R, Finkenstett G, Hogue-Angeletti R, Fischer-Colbrie R (1991) Chromogranin A and B in adenomas of the pituitary. An immunohistochemical study of 42 cases. Am J Surg Pathol 15:1072-1077
21. Scopsi L, Andreola S, Pilotti S, Testori A, Baldini MT, Leoni F, Lombardi L, Hutton JC, Shimizu F, Rosa P (1992) Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters. Am J Surg Pathol 16:561-576
22. Senden NH, Timmer ED, de Bruine A, Wagenaar SS, Van de Velde HJ, Roebroek AJ, Van de Ven WJ, Broers JL, Ramaekers FC (1997) A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers. J Pathol 182:13-21
23. Syversen U, Halvorsen T, Marvik R, Waldum HL (1995) Neuroendocrine differentiation in colorectal carcinomas. Eur J Gastroenterol Hepatol 7:667-674
24. Taupenot L, Harper KL, O'Connor DT (2003) The chromogranin-secretogranin family. N Engl J Med 348:1134-1149
25. Wagner L, Templ E, Reining G, Base W, Weissel M, Nowotny P, Kaserer K, Waldhausl W (1998) Culture of human insulinoma cells: development of a neuroendocrine tumour cell- and human pancreatic islet cell-specific monoclonal antibody. J Endocrinol 156:469-476
26. Wagner L, Oliyarnyk O, Gartner W, Nowotny P, Groeger M, Kaserer K, Waldhausl W, Pasternack MS (2000) Cloning and expression of secretagogin, a novel neuroendocrine and pancreatic islet of Langerhans-specific Ca2+-binding protein. J Biol Chem 275:24740-24751
27. Weiler R, Fischer-Colbrie R, Schmid KW, Feichtinger H, Bussolati G, Grimelius L, Krisch K, Kerl H, O'Connor D, Winkler H (1988) Immunological studies on the occurrence and properties of chromogranin A and B and secretogranin in endocrine tumours. Am J Surg Pathol 12:877-884
28. Wilson BS, Lloyd RV (1984) Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 115:458-468
29. Xing X, Lai M, Gartner W, Xu E, Huang Q, Li H, Chen G (2006) Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin. Proteomics 6:2916-2923
30. Yu DS, Hsieh DS, Chen HI, Chang SY (2001) The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications. J Urol 166:871-875
31. Zhan X, Evans CO, Oyesiku NM, Desiderio DM (2003) Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas. Pituitary 6:189-202